These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 4262647

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of Thio-TEPA on advanced ovarian cancer (author's transl)].
    Luciani L, De Palo GM, Conti U, Mattavelli F, Di Re F.
    Tumori; 1973; 59(4):259-67. PubMed ID: 4357004
    [No Abstract] [Full Text] [Related]

  • 5. Phase II trial of thio-TEPA in relapsed and refractory ovarian carcinoma.
    Langer CJ, Nash S, Catalano R, Rosenblum NG, Hogan WM, Comis RL, O'Dwyer PJ.
    Gynecol Oncol; 1991 Dec; 43(3):242-6. PubMed ID: 1752494
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The stroma of immature cilioepithelial tumors of the ovaries].
    Torgushina NS, Kozhevnikova IN, Zefirova NP, Bushuev IuI.
    Arkh Patol; 1971 Dec; 33(12):53-8. PubMed ID: 4260206
    [No Abstract] [Full Text] [Related]

  • 8. Thio-TEPA and supervoltage radiotherapy for carcinoma of the ovary.
    Deutsch M, Parsons JA.
    Cancer; 1972 Apr; 29(4):1038-42. PubMed ID: 4622786
    [No Abstract] [Full Text] [Related]

  • 9. [Chemotherapy of epithelial ovarian cancer: CHexUP versus thio-tepa].
    Wu BZ.
    Zhonghua Fu Chan Ke Za Zhi; 1987 Jan; 22(1):5-8, 61. PubMed ID: 3109851
    [No Abstract] [Full Text] [Related]

  • 10. Topical use of Thio-Tepa for tumours of the bladder.
    Oravisto KJ.
    Urol Int; 1965 Jan; 20(1):23-8. PubMed ID: 4953655
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thio-tepa chemotherapy for ovarian carcinoma. Influence of remission and toxicity on survival.
    Wallach RC, Kabakow B, Blinick G, Antopol W.
    Obstet Gynecol; 1970 Feb; 35(2):278-86. PubMed ID: 4189962
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Chemotherapy of patients with recurring malignant tumors of the ovaries].
    Kotova DG, Vinokurov VL.
    Vopr Onkol; 1975 Feb; 21(4):19-23. PubMed ID: 812259
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The use of Thio-TEPA in patients with malignant diseases of the ovary].
    Kuz'mina NA.
    Akush Ginekol (Mosk); 1966 Apr; 42(4):10-3. PubMed ID: 4965157
    [No Abstract] [Full Text] [Related]

  • 18. Thio-TEPA and methotrexate chemotherapy of advanced ovarian carcinoma.
    Greenspan EM.
    J Mt Sinai Hosp N Y; 1968 Apr; 35(1):52-67. PubMed ID: 4966488
    [No Abstract] [Full Text] [Related]

  • 19. [Thio-tepa in the prevention of recurrences of papillary bladder tumors].
    Kierfeld G, Mellin P.
    Z Urol Nephrol; 1973 Aug; 66(8):569-72. PubMed ID: 4204011
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of advanced inoperable ovarian carcinoma with thio-tepa.
    Blinick G, Kabakow B, Wallach RC, Antopol W.
    Am J Obstet Gynecol; 1966 Oct 01; 96(3):425-9. PubMed ID: 4958483
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.